Photosensitizing effect of protoporphyrin IX in pigmented melanoma of mice

Biochemical and Biophysical Research Communications

Volumn 297, Issue 3, 2002, Pages 468-472

  Juzenas, Petras ^a,b   Juzeniene, Asta ^a   Stakland, Silje ^a   Iani, Vladimir ^a   Moan, Johan ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b VILNIUS UNIVERSITY   (Lithuania)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

5 Aminolevulinic acid; Extraction; Fluorescence; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; ESTER DERIVATIVE; PROTOPORPHYRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FLUORESCENCE; LASER; LIGHT; MELANOMA; MOUSE; NONHUMAN; PHOTOSENSITIZATION; PRIORITY JOURNAL; TUMOR GROWTH;

ADMINISTRATION, TOPICAL; ALAMETHICIN; AMINOLEVULINIC ACID; ANIMALS; CELL DIVISION; HUTCHINSON'S MELANOTIC FRECKLE; MELANOMA, EXPERIMENTAL; MICE; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; SKIN NEOPLASMS; SPECTROMETRY, FLUORESCENCE; TUMOR CELLS, CULTURED;

EID: 0036386150     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02238-6     Document Type: Article

References (33)

1. T.J. Dougherty, C.J. Gomer, B.W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, Q. Peng, Photodynamic therapy, J. Natl. Cancer Inst. 90 (1998) 889-905.
2. J.C. Kennedy, R.H. Pottier, Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy, J. Photochem. Photobiol. B 14 (1992) 275-292.
3. Q. Peng, T. Warloe, K. Berg, J. Moan, M. Kongshaug, K.E. Giercksky, J.M. Nesland, 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges, Cancer 79 (1997) 2282-2308.
4. C. Fritsch, C. Abels, A.E. Goetz, W. Stahl, K. Bolsen, T. Ruzicka, G. Goerz, H. Sies, Porphyrins preferentially accumulate in a melanoma following intravenous injection of 5-aminolevulinic acid, Biol. Chem. 378 (1997) 51-57.
5. S.L. Gibson, D.J. Cupriks, J.J. Havens, M.L. Nguyen, R. Hilf, A regulatory role for porphobilinogen deaminase (PBGD) in δ-aminolaevulinic acid (δ-ALA)-induced photosensitization? Br. J. Cancer 77 (1998) 235-243.
6. M.M. el Sharabasy, A.M. el Waseef, M.M. Hafez, S.A. Salim, Porphyrin metabolism in some malignant diseases, Br. J. Cancer 65 (1992) 409-412.
7. R. van Hillegersberg, J.W. Van den Berg, W.J. Kort, O.T. Terpstra, J.H. Wilson, Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats, Gastroenterology 103 (1992) 647-651.
8. K. Rittenhouse-Diakun, H. van Leengoed, J. Morgan, E. Hryhorenko, G. Paszkiewicz, J.E. Whitaker, A.R. Oseroff, The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor δ-aminolevulinic acid (ALA), Photochem. Photobiol. 61 (1995) 523-528.
9. J. Moan, J.H.T.M. van den Akker, P. Juzenas, L.W. Ma, E. Angell-Petersen, Ø.B. Gadmar, V. Iani, On the basis for tumor selectivity in the 5-aminolevulinic acid-induced synthesis of protoporphyrin IX, J. Porphyr. Phthalocyanines 5 (2001) 170-176.
10. J.M. Gaullier, K. Berg, Q. Peng, H. Anholt, P.K. Selbo, L.W. Ma, J. Moan, Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture, Cancer Res. 57 (1997) 1481-1486.
11. J. Kloek, W. Akkermans, G.M. Beijersbergen Van Henegouwen, Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin, Photochem. Photobiol. 67 (1998) 150-154.
12. C. Fritsch, B. Homey, W. Stahl, P. Lehmann, T. Ruzicka, H. Sies, Preferential relative porphyrin enrichment in solar keratoses upon topical application of δ-aminolevulinic acid methylester, Photochem. Photobiol. 68 (1998) 218-221.
13. P. Uehlinger, M. Zellweger, G. Wagnieres, L. Juillerat-Jeanneret, H. van den Bergh, N. Lange, 5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells, J. Photochem. Photobiol. B 54 (2000) 72-80.
14. C. Fritsch, G. Goerz, T. Ruzicka, Photodynamic therapy in dermatology, Arch. Dermatol. 134 (1998) 207-214.
15. K. Kalka, H. Merk, H. Mukhtar, Photodynamic therapy in dermatology, J. Am. Acad. Dermatol. 42 (2000) 389-413.
16. T.J. Dougherty, Photoradiation therapy for cutaneous and subcutaneous malignancies, J. Invest. Dermatol. 77 (1981) 122-124.
17. P. Wolf, E. Rieger, H. Kerl, Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? J. Am. Acad. Dermatol. 28 (1993) 17-21.
18. I. Favilla, W.R. Barry, A. Gosbell, P. Ellims, F. Burgess, Phototherapy of posterior uveal melanomas, Br. J. Ophthalmol. 75 (1991) 718-721.
19. C. Abels, C. Fritsch, K. Bolsen, R.M. Szeimies, T. Ruzicka, G. Goerz, A.E. Goetz, Photodynamic therapy with 5-aminolaevulinic acid-induced porphyrins of an amelanotic melanoma in vivo, J. Photochem. Photobiol. B 40 (1997) 76-83.
20. S. Pahernik, S. Langer, A. Botzlar, M. Dellian, A.E. Goetz, Tissue distribution and penetration of 5-ALA-induced fluorescence in an amelanotic melanoma after topical application, Anticancer Res. 21 (2001) 59-63.
21. T.J. Dougherty, J.E. Kaufman, A. Goldfarb, K.R. Weishaupt, D. Boyle, A. Mittleman, Photoradiation therapy for the treatment of malignant tumors, Cancer Res. 38 (1978) 2628-2635.
22. S. Karrer, R.M. Szeimies, U. Hohenleutner, M. Landthaler, Role of lasers and photodynamic therapy in the treatment of cutaneous malignancy, Am. J. Clin. Dermatol. 2 (2001) 229-237.
23. K. Magnus, The Nordic profile of skin cancer incidence. A comparative epidemiological study of the three main types of skin cancer, Int. J. Cancer 47 (1991) 12-19.
24. J. Moan, A. Dahlback, R.B. Setlow, Epidemiological support for an hypothesis for melanoma induction indicating a role for UVA radiation, Photochem. Photobiol. 70 (1999) 243-247.
25. S. Brenner, E. Tamir, Early detection of melanoma: the best strategy for a favorable prognosis, Clin. Dermatol. 20 (2002) 203-211.
26. A. Busetti, M. Soncin, G. Jori, M.A. Rodgers, High efficiency of benzoporphyrin derivative in the photodynamic therapy of pigmented malignant melanoma, Br. J. Cancer 79 (1999) 821-824.
27. C.J. Gomer, J.V. Jester, N.J. Razum, B.C. Szirth, A.L. Murphree, Photodynamic therapy of intraocular tumors: examination of hematoporphyrin derivative distribution and long-term damage in rabbit ocular tissue, Cancer Res. 45 (1985) 3718-3725.
28. Q. Peng, J. Moan, T. Warloe, J.M. Nesland, C. Rimington, Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma, Int. J. Cancer 52 (1992) 433-443.
29. N. Schoenfeld, R. Mamet, Y. Nordenberg, M. Shafran, T. Babushkin, Z. Malik, Protoporphyrin biosynthesis in melanoma B16 cells stimulated by 5-aminolevulinic acid and chemical inducers: characterization of photodynamic inactivation, Int. J. Cancer 56 (1994) 106-112.
30. H. Lui, R.R. Anderson, Photodynamic therapy in dermatology: recent developments, Dermatol. Clin. 11 (1993) 1-13.
31. A.S. Ito, G.C. Azzellini, S.C. Silva, O. Serra, A.G. Szabo, Optical absorption and fluorescence spectroscopy studies of ground state melanin-cationic porphyrins complexes, Biophys. Chem. 45 (1992) 79-89.
32. A. Losi, R. Bedotti, L. Brancaleon, C. Viappiani, Porphyrin-melanin interaction: effect on fluorescence and non-radiative relaxations, J. Photochem. Photobiol. B 21 (1993) 69-76.
33. R. Haddad, A. Blumenfeld, A. Siegal, O. Kaplan, M. Cohen, Y. Skornick, H. Kashtan, In vitro and in vivo effects of photodynamic therapy on murine malignant melanoma, Ann. Surg. Oncol. 5 (1998) 241-247.